164 related articles for article (PubMed ID: 30217623)
1. Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases.
Kalhor N; Moran CA
Hum Pathol; 2019 Jan; 83():100-105. PubMed ID: 30217623
[TBL] [Abstract][Full Text] [Related]
2. Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases.
Kalhor N; Moran CA
Hum Pathol; 2019 Apr; 86():124-128. PubMed ID: 30537491
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyomatous thymoma.
Moran CA; Koss MN
Am J Surg Pathol; 1993 Jun; 17(6):633-6. PubMed ID: 8333562
[TBL] [Abstract][Full Text] [Related]
4. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.
Kalhor N; Moran CA
Hum Pathol; 2018 Apr; 74():73-82. PubMed ID: 29339175
[TBL] [Abstract][Full Text] [Related]
5. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.
Suster S; Moran CA
Am J Surg Pathol; 1996 Dec; 20(12):1469-80. PubMed ID: 8944040
[TBL] [Abstract][Full Text] [Related]
6. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
7. Thymomas with prominent glandular differentiation: a clinicopathologic and immunohistochemical study of 12 cases.
Weissferdt A; Moran CA
Hum Pathol; 2013 Aug; 44(8):1612-6. PubMed ID: 23528863
[TBL] [Abstract][Full Text] [Related]
8. Thymoma with pseudosarcomatous stroma: report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma.
Suster S; Moran CA; Chan JK
Am J Surg Pathol; 1997 Nov; 21(11):1316-23. PubMed ID: 9351569
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyomatous carcinoma of the thymus.
de Queiroga EM; Chikota H; Bacchi CE; Moran CA; Suster S
Am J Surg Pathol; 2004 Sep; 28(9):1245-50. PubMed ID: 15316327
[TBL] [Abstract][Full Text] [Related]
10. Micronodular Thymomas With Prominent Cystic Changes: A Clinicopathological and Immunohistochemical Study of 25 Cases.
Oramas DM; Moran CA
Int J Surg Pathol; 2021 Jun; 29(4):352-357. PubMed ID: 33026263
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
[TBL] [Abstract][Full Text] [Related]
12. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
13. Cystic and Encapsulated Atypical Thymoma (World Health Organization Type B3).
Lindholm KE; Moran CA
Am J Clin Pathol; 2019 Sep; 152(4):512-516. PubMed ID: 31184706
[TBL] [Abstract][Full Text] [Related]
14. Thymomas With Extensive Clear Cell Component: A Clinicopathologic and Immunohistochemical Study of Nine Cases.
Weissferdt A; Kalhor N; Moran CA
Am J Clin Pathol; 2016 Jul; 146(1):132-6. PubMed ID: 27371363
[TBL] [Abstract][Full Text] [Related]
15. Basaloid Squamous Cell Carcinomas of the Thymus With Prominent B-Cell Lymphoid Hyperplasia: A Clinicopathologic and Immunohistochemical Study of 10 Cases.
Weissferdt A; Moran CA
Am J Surg Pathol; 2023 Sep; 47(9):1039-1044. PubMed ID: 37341090
[TBL] [Abstract][Full Text] [Related]
16. Chromophobe-like carcinoma of the thymus: A clinicopathological and immunohistochemical correlation of 5 cases.
Weissferdt A; Moran CA
Pathol Res Pract; 2023 Aug; 248():154629. PubMed ID: 37348289
[TBL] [Abstract][Full Text] [Related]
17. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
Jeong YJ; Lee KS; Kim J; Shim YM; Han J; Kwon OJ
AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013
[TBL] [Abstract][Full Text] [Related]
18. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.
Meurgey A; Girard N; Merveilleux du Vignaux C; Maury JM; Tronc F; Thivolet-Bejui F; Chalabreysse L
J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035
[TBL] [Abstract][Full Text] [Related]
20. Expression of cathepsins V and S in thymic epithelial tumors.
Kiuchi S; Tomaru U; Ishizu A; Imagawa M; Kiuchi T; Iwasaki S; Suzuki A; Otsuka N; Deguchi T; Shimizu T; Marukawa K; Matsuno Y; Kasahara M
Hum Pathol; 2017 Feb; 60():66-74. PubMed ID: 27771373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
